NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 48 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $42,342,000 | -17.2% | 30,770,000 | 0.0% | 0.17% | -25.2% |
| Q2 2020 | $51,144,000 | +30.1% | 30,770,000 | 0.0% | 0.23% | -6.6% |
| Q1 2020 | $39,321,000 | -16.6% | 30,770,000 | 0.0% | 0.24% | -3.6% |
| Q4 2019 | $47,123,000 | +11.9% | 30,770,000 | 0.0% | 0.25% | -12.2% |
| Q3 2019 | $42,113,000 | +3.9% | 30,770,000 | 0.0% | 0.29% | +3.6% |
| Q2 2019 | $40,541,000 | -43.7% | 30,770,000 | -42.2% | 0.28% | -40.1% |
| Q1 2019 | $71,994,000 | +13.5% | 53,270,000 | 0.0% | 0.46% | -11.2% |
| Q4 2018 | $63,434,000 | +271.8% | 53,270,000 | +432.7% | 0.52% | +363.4% |
| Q3 2018 | $17,062,000 | +17.9% | 10,000,000 | 0.0% | 0.11% | +2.8% |
| Q2 2018 | $14,466,000 | – | 10,000,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |